SG11201700557RA - Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells - Google Patents

Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells

Info

Publication number
SG11201700557RA
SG11201700557RA SG11201700557RA SG11201700557RA SG11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA
Authority
SG
Singapore
Prior art keywords
lipid
membrane
immobilization carrier
fusing cells
fusing
Prior art date
Application number
SG11201700557RA
Other languages
English (en)
Inventor
Takumi Hirase
Rii MORIMURA
Masato Nakayama
Original Assignee
Toppan Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toppan Printing Co Ltd filed Critical Toppan Printing Co Ltd
Publication of SG11201700557RA publication Critical patent/SG11201700557RA/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/20After-treatment of capsule walls, e.g. hardening
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Materials Engineering (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Colloid Chemistry (AREA)
SG11201700557RA 2014-07-24 2015-07-24 Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells SG11201700557RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014150868 2014-07-24
PCT/JP2015/071118 WO2016013660A1 (ja) 2014-07-24 2015-07-24 脂質膜構造体、脂質膜構造体固定化担体、及び胞体の融合方法

Publications (1)

Publication Number Publication Date
SG11201700557RA true SG11201700557RA (en) 2017-02-27

Family

ID=55163182

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700557RA SG11201700557RA (en) 2014-07-24 2015-07-24 Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells

Country Status (6)

Country Link
US (2) US10807061B2 (ja)
EP (1) EP3173143A4 (ja)
JP (1) JP6597614B2 (ja)
CN (1) CN106573220B (ja)
SG (1) SG11201700557RA (ja)
WO (1) WO2016013660A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017141947A1 (ja) * 2016-02-15 2017-08-24 凸版印刷株式会社 エクソソーム複合体の形成方法
KR101962172B1 (ko) * 2017-09-20 2019-07-18 서강대학교산학협력단 자성 광합성 세포막 소낭을 이용한 트랜스-레스베라트롤의 생산 방법
CN108546671A (zh) * 2018-04-17 2018-09-18 马英淙 一种生物样品中细胞微囊泡的分离方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442133B2 (ja) 1994-03-03 2003-09-02 Tdk株式会社 磁性細菌マグネトソーム及び遺伝子を含有するリポソーム並びにそれを利用する細胞への遺伝子の導入方法
US5591448A (en) 1994-11-21 1997-01-07 Tepic; Slobodan Anti-viral therapeutic composition
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
US20040241176A1 (en) 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
EP1548439A4 (en) * 2002-09-13 2008-04-23 Hitachi Chemical Co Ltd FIXIERTRUGER AND FIXED PHASE
ATE491781T1 (de) * 2003-06-30 2011-01-15 Eisai R&D Man Co Ltd Magnetische zelle und verfahren zur verwendung davon
EP1548444A1 (en) * 2003-12-23 2005-06-29 Paul Scherrer Institut An assay chip, and uses of said assay chip to determine molecular structures and functions
JP2006034211A (ja) * 2004-07-29 2006-02-09 Nagoya Institute Of Technology 酸性条件で膜融合を促進するペプチド誘導体
JP2008029952A (ja) * 2006-07-28 2008-02-14 National Institute Of Advanced Industrial & Technology ベシクルを利用した並列反応方法
JP2008081486A (ja) * 2006-08-31 2008-04-10 Canon Inc 細胞融合性リポソーム及び該リポソームを利用した物質導入方法
CN101657719A (zh) 2007-01-26 2010-02-24 路易斯维尔大学研究基金会公司 检测用于诊断和表征障碍的自身抗体的方法
EP2806273B1 (en) 2007-07-25 2017-09-06 University of Louisville Research Foundation, Inc. Exosome-associated microRNA as a diagnostic marker
US20110177054A1 (en) 2008-06-06 2011-07-21 Derrick Gibbings Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
JP2012508233A (ja) * 2008-11-07 2012-04-05 チルドレンズ ホスピタル メディカル センター 膜貫通薬物送達システムへの適用のためのサポシンc、並びに関連のタンパク質及びペプチドの融合性
WO2010085259A1 (en) * 2009-01-26 2010-07-29 Nanotrope, Inc. Viral detection liposomes and method
EP3569254B1 (en) 2009-04-17 2022-07-20 Oxford University Innovation Limited Composition for delivery of genetic material
AU2011204625B2 (en) 2010-01-08 2014-05-22 Cavadis B.V. Determination of exosomal biomarkers for predicting cardiovascular events
JP2013007698A (ja) 2011-06-27 2013-01-10 Univ Of Miyazaki 腎における小胞体ストレス応答の検出方法
DE102013009744A1 (de) * 2013-03-26 2014-10-02 Forschungszentrum Jülich GmbH Fusionsmischung zur lipidhaltigen Membranmodifikation einer beliebigen Lipidmembran, einer Zellmembran, einem Bestandteil einer Zellmembran oder einer von den übrigen Zell- Bestandteilen getrennten Zellmembran in vivo oder in vitro

Also Published As

Publication number Publication date
CN106573220A (zh) 2017-04-19
US20200406219A1 (en) 2020-12-31
CN106573220B (zh) 2019-08-16
EP3173143A1 (en) 2017-05-31
EP3173143A4 (en) 2018-06-27
JPWO2016013660A1 (ja) 2017-06-15
US20170128904A1 (en) 2017-05-11
US10807061B2 (en) 2020-10-20
WO2016013660A1 (ja) 2016-01-28
JP6597614B2 (ja) 2019-10-30

Similar Documents

Publication Publication Date Title
SG11201706826VA (en) Method for separating cells, and device therefor
EP3217064A4 (en) Hydrogen station
EP3321979A4 (en) METHOD OF MANUFACTURING A LOCAL BACK CONTACT SOLAR CELL
PT3174813T (pt) Embalagem, sistema e método para preparar bebidas
IL247445A0 (en) System and method for gliding cells and monitoring
EP3203530A4 (en) Solar cell and method for manufacturing same
EP3236559A4 (en) Electrical storage system, and electrical storage method
EP3124432A4 (en) Hydrogen generation system and hydrogen generation method
EP3176905A4 (en) Electrical storage system, and electrical storage method
EP3133865A4 (en) Method, device and system for cell reselection
EP3091786A4 (en) Apparatus, method and system for cell selection
EP3378933A4 (en) PROCESS FOR PREPARING CELL
EP3091067A4 (en) Cell tray and device, method and system for producing cell structure
EP3168917A4 (en) Liquid electrolyte, and method for manufacturing phosphate
EP3157062A4 (en) Solar cell and method for manufacturing solar cell
EP3206433A4 (en) Inter-small cell switching method, device and system
IL266111A (en) Methods for inducing a t-cell response
EP3187578A4 (en) Cell trapping method, method for producing specific cell-trapping device, and method for producing specific cell-containing solution
EP3220464A4 (en) Cell structure, method for producing same, and fuel cell
EP3237897A4 (en) Electrochemical testing system
EP3099122A4 (en) Method, cell, and system for implementing air interface synchronization
IL248598A0 (en) Foods, systems, methods and kits for providing electrolyte replacements
EP3208329A4 (en) Method for producing gamma-delta t cells, and pharmaceutical
EP3358003A4 (en) Method for manufacturing sheet-shaped cell structure, and sheet-shaped cell structure
EP3111945A4 (en) Pharmaceutical containing dendritic cells, and method for producing same